Post K D, Biller B J, Adelman L S, Molitch M E, Wolpert S M, Reichlin S
JAMA. 1979 Jul 13;242(2):158-62.
Thirty women with prolactin (PRL)-secreting adenomas underwent selective adenomectomy via a transsphenoidal route. All had abnormal sella polytomes or visual fields, amenorrhea with low basal serum gonadotropin levels despite decreased serum estradiol concentrations, and elevated basal serum PRL levels with blunted PRL response to neuroendocrine stimulation tests )thyrotropin-releasing hormone, levodopa, chlorpromazine, and hypoglycemia). Of 17 patients with microadenomas, 14 (82.4%) were cured and three (17.6%) improved. None were unchanged or worse. Three (60%) of five patients with larger, but still intrasellar tumors, had normalization of PRL levels, return of menses, and resolution of galactorrhea. The patients with tumors extending out of the sella did not fare as well. Overall, 21 (70%) were cured, six (20%) improved, two (6.7%) were unchanged, and the condition of one (3.3%) became worse. All preoperative neurologic deficits resolved. Postoperative complications were minimal with no neurologic morbidity. When tumors are small, surgical results are excellent with minimal risk.
30例患有分泌催乳素(PRL)腺瘤的女性通过经蝶窦途径接受了选择性腺瘤切除术。所有患者均有蝶鞍断层扫描异常或视野缺损,尽管血清雌二醇浓度降低,但仍有闭经且基础血清促性腺激素水平较低,基础血清PRL水平升高,且PRL对神经内分泌刺激试验(促甲状腺激素释放激素、左旋多巴、氯丙嗪和低血糖)反应迟钝。17例微腺瘤患者中,14例(82.4%)治愈,3例(17.6%)病情改善。无一例病情无变化或恶化。5例肿瘤较大但仍局限于鞍内的患者中,3例(60%)PRL水平恢复正常、月经复潮且溢乳症状消失。肿瘤延伸至鞍外的患者预后较差。总体而言,21例(70%)治愈,6例(20%)病情改善,2例(6.7%)病情无变化,1例(3.3%)病情恶化。所有术前神经功能缺损均得到缓解。术后并发症极少,无神经功能障碍。当肿瘤较小时,手术效果极佳,风险极小。